Your browser doesn't support javascript.
loading
Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab.
Cañas, Amanda; López-Sánchez, Laura M; Peñarando, Jon; Valverde, Araceli; Conde, Francisco; Hernández, Vanessa; Fuentes, Elena; López-Pedrera, Chary; de la Haba-Rodríguez, Juan R; Aranda, Enrique; Rodríguez-Ariza, Antonio.
Afiliação
  • Cañas A; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: amandacanasrodriguez@gmail.com.
  • López-Sánchez LM; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: lmlopezsanchez@gmail.com.
  • Peñarando J; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: jon_aries80@hotmail.com.
  • Valverde A; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: aracelivalverdeestepa@hotmail.es.
  • Conde F; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: fmcp@usal.es.
  • Hernández V; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: vanessa-septiembre@hotmail.com.
  • Fuentes E; Pathology Department, IMIBIC, Reina Sofía Hospital, University of Córdoba, Spain. Electronic address: elena.fuentes.sspa@juntadeandalucia.es.
  • López-Pedrera C; Research Unit, IMIBIC, Reina Sofía Hospital, University of Córdoba, Córdoba, Spain. Electronic address: rosario.lopez.exts@juntadeandalucia.es.
  • de la Haba-Rodríguez JR; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: juahaba@gmail.com.
  • Aranda E; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: earandaa@seom.org.
  • Rodríguez-Ariza A; Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spain; Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: antonio.rodriguez.exts@juntadeandalucia.es.
Biochim Biophys Acta ; 1862(4): 601-610, 2016 04.
Article em En | MEDLINE | ID: mdl-26854735

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / S-Nitrosotióis / Trastuzumab / Homeostase Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Biochim Biophys Acta Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Resistencia a Medicamentos Antineoplásicos / S-Nitrosotióis / Trastuzumab / Homeostase Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: En Revista: Biochim Biophys Acta Ano de publicação: 2016 Tipo de documento: Article